Most Recent
ASIC has flagged it may seek an initial trial on whether comparison website company Clark Family provided financial services to consumers, in its case alleging the company sold customer enquiries to the highest bidder.
A judge has ordered Star Entertainment to pay a $260 million penalty for anti-money laundering and counter-terrorism financing failures, saying the casino turned a “blind eye” to customers likely linked to organised crime.
Investment firm White Oak has settled its case against IAG, Tokio Marine and subsidiary BCC alleging the insurers were liable for $200 million in damages following the collapse of supply chain finance company Greensill.
REA Group must hand over communications with Deloitte in draft versions of a report said to back the real estate listing giant's promotional claim that '9 in 10 buyers' find a home on its site, a claim rival Domain says is misleading and deceptive.
A former senior associate at Wotton Kearney has brought a Fair Work case against the law firm, alleging he was unfairly dismissed from his role.
Construction PRO
REA Group has been ordered to produce communications with Deloitte in a lawsuit over a promotional claim that rival real estate listings company Domain says is misleading.
Mineral Resources managing director Chris Ellison has lost his bid to strike out an unfair dismissal claim by a former in-house lawyer for the company, who told the court Ellison said “just get rid of her” in a 2024 meeting.
Construction PRO
A subsidiary of civil construction company Ian Harrington Group wants to revise its defence to a $3.6 million case by Sibayne Stillwater’s Copper Mines of Tasmania, arguing it has no obligation to rehabilitate a quarry at the shuttered Mt Lyell mine.
The Federal Court is grappling with “substantial and evolving” pressures as the number of filings rose to 6,010 over the past year, including an “exponential rise” in the numbers of self-represented litigants.
Swiss pharmaceutical company Actelion has brought a fourth patent infringement case over plans to launch a generic version of its blood pressure drug in Australia -- against Lupin unit Generic Health -- after firing off cases against three other drug makers.